XML 29 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net income (loss) $ 39,636 $ (54,235) $ (66,206)
Adjustments to reconcile net income (loss) to cash flows provided by operating activities:      
Depreciation and amortization of property and equipment 16,728 13,539 14,105
Amortization of intangible assets 44,193 50,862 56,891
Amortization of debt issuance costs and original issue discount 2,802 4,847 3,241
Amortization of accumulated other comprehensive gain related to interest rate swap   (8,196) (5,575)
Stock-based compensation 19,406 16,086 21,806
Deferred income taxes (85,603) (16,887) (9,196)
Gain on sale of swap     (7,301)
Change in fair value of warrant liability (5,995) 2,769 (201)
Change in fair value of preferred stock liability   8,091 1,548
Dividends accrued on preferred stock liability   2,743 3,935
Payment of dividends accrued on preferred stock liability   (6,686)  
Foreign currency exchange losses (gains) 3,653 5,741 (44)
Changes in operating assets and liabilities:      
Accounts receivable 20,028 12,420 5,726
Inventory 234 (3,616) (10,701)
Other operating assets (564) 30,459 34,834
Accounts payable (3,257) (6,016) (10,498)
Accrued expenses and other long-term liabilities (15,656) (9,367) (14,684)
Deferred revenue 15,793 7,686 (593)
Net cash provided by operating activities 51,398 50,240 17,087
Cash flows from investing activities:      
Purchases of property and equipment (25,342) (22,406) (9,381)
Purchases of software licenses   (462) (100)
Net cash used in investing activities (25,342) (22,868) (9,481)
Cash flows from financing activities:      
Borrowings under revolving line of credit   44,106 97,000
Principal payments on revolving line of credit   (44,106) (97,000)
Proceeds from issuance of term debt   342,300  
Principal payments of term debt (6,125) (237,145) (95,058)
Payment of debt issuance costs   (6,312) (1,685)
Proceeds from issuance of preferred stock and warrant liabilities     53,350
Payment of preferred stock liability   (56,850)  
Proceeds from the exercise of stock options 6 21 15
Payment of tax obligations related to vested stock awards and units (4,357) (4,308) (4,481)
Repurchase of common stock (8,955)    
Net cash (used in) provided by financing activities (19,431) 37,706 (47,859)
Effect of exchange rate changes on cash and cash equivalents 1,027 (1,229) (379)
Net increase (decrease) in cash and cash equivalents 7,652 63,849 (40,632)
Cash, cash equivalents and restricted cash, beginning of year 90,479 26,630 67,262
Cash, cash equivalents and restricted cash, end of year 98,131 90,479 26,630
Supplemental disclosure of cash flow information:      
Interest paid 37,998 32,969 25,573
Income taxes paid 11,950 29,280 18,876
Income tax refunds received 1,428 1,545 1,611
Supplemental disclosure of non-cash investing activities:      
Capital expenditures incurred, but not yet paid 4,511 10,090 2,578
Inventory transfers to property and equipment 2,159 2,165 1,693
Supplemental disclosure of non-cash financing activities:      
Warrant liability released to additional paid-in-capital 150    
Fair value of vested restricted and performance-based stock grants $ 14,103 $ 14,822 $ 15,571